Biosimilar Approval Brings New Awareness Levels for Community Pharmacists
April 15th 2015The FDA's March 6, 2015, Zarxio approval brought biosimilars into the spotlight once again, although Zarxio and other biosimilars continue to face hurdles. Community pharmacists should remain aware of the therapies in order to better assist their patients.
Read More